Effects of renalase deficiency on liver fibrosis markers in a nonalcoholic steatohepatitis mouse model

被引:12
|
作者
Tokinoya, Katsuyuki [1 ]
Sekine, Nanami [2 ]
Aoki, Kai [1 ]
Ono, Seiko [2 ]
Kuji, Tomoaki [1 ]
Sugasawa, Takehito [3 ]
Yoshida, Yasuko [4 ]
Takekoshi, Kazuhiro [3 ]
机构
[1] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Sports Med, Tsukuba, Ibaraki 3058577, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan
[3] Univ Tsukuba, Div Clin Med, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan
[4] Tsukuba Int Univ, Dept Clin Lab Sci, Fac Hlth Sci, Tsuchiura, Ibaraki 3000051, Japan
关键词
transforming growth factor-beta; alpha-smooth muscle actin; Akt; oxidative stress; liver; renalase; OXIDATIVE STRESS; PATHWAY; INFLAMMATION; CONTRIBUTES; CELLS;
D O I
10.3892/mmr.2021.11849
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Progression of nonalcoholic steatohepatitis (NASH) is attributed to several factors, including inflammation and oxidative stress. In recent years, renalase has been reported to suppress oxidative stress, apoptosis and inflammation. A number of studies have suggested that renalase may be associated with protecting the liver from injury. The present study aimed to clarify the effects of renalase knockout (KO) in mice with NASH that were induced with a choline-deficient high-fat diet (CDAHFD) supplemented with 0.1% methionine. Wild type (WT) and KO mice (6-week-old) were fed a normal diet (ND) or CDAHFD for 6 weeks, followed by analysis of the blood liver function markers and liver tissues. CDAHFD intake was revealed to increase blood hepatic function markers, lipid accumulation and oxidative stress compared with ND, but no significant differences were observed between the WT and KO mice. However, in the KO-CDAHFD group, the Adgre1 and Tgfb1 mRNA levels were significantly higher, and alpha-SMA expression was significantly lower compared with the WT-CDAHFD group. Furthermore, the Gclc mRNA and phosphorylated protein kinase B (Akt) levels were significantly lower in the KO-ND group compared with the WT-ND group. The results of the current study indicated that as NASH progressed in the absence of renalase, oxidative stress, macrophage infiltration and TGF-beta expression were enhanced, while alpha-SMA expression in NASH may be partly suppressed due to the decreased phosphorylation of Akt level.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Hepatic Zonation in a Nonalcoholic Steatohepatitis Mouse Model
    Huh, Won Jae
    Albanese, Joseph M.
    Salavaggione, Lorena
    Liu, Qiang
    Neuschwander-Tetri, Brent A.
    Brunt, Elizabeth M.
    GASTROENTEROLOGY, 2013, 144 (05) : S963 - S963
  • [42] HEPATOCYTE EXTRACELLULAR VESICLES ATTENUATE LIVER FIBROSIS AND INFLAMMATION IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS
    Li, Xinlei
    Chen, Ruju
    Kemper, Sherri
    Brigstock, David
    HEPATOLOGY, 2020, 72 : 1019 - 1019
  • [43] MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis
    Csak, Timea
    Bala, Shashi
    Lippai, Dora
    Kodys, Karen
    Catalano, Donna
    Iracheta-Vellve, Arvin
    Szabo, Gyongyi
    PLOS ONE, 2015, 10 (06):
  • [44] Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice
    Nakayama, Hitomi
    Otabe, Shuichi
    Yuan, Xiaohong
    Ueno, Takato
    Hirota, Naotoshi
    Fukutani, Tomoka
    Wada, Nobuhiko
    Hashinaga, Toshihiko
    Yamada, Kentaro
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (07): : 901 - 908
  • [45] DEFICIENCY OF FORMYL PEPTIDE RECEPTOR 2 EXACERBATES LIVER INFLAMMATION AND FIBROSIS IN MICE WITH NONALCOHOLIC FATTY LIVER DISEASE/STEATOHEPATITIS
    Lee, Chanbin
    Kim, Jieun
    Wang, Sihyung
    Jung, Youngmi
    HEPATOLOGY, 2019, 70 : 1337A - 1338A
  • [46] Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
    Zhu, Changyu
    Kim, KyeongJin
    Wang, Xiaobo
    Bartolome, Alberto
    Salomao, Marcela
    Dongiovanni, Paola
    Meroni, Marica
    Graham, Mark J.
    Yates, Katherine P.
    Diehl, Anna Mae
    Schwabe, Robert F.
    Tabas, Ira
    Valenti, Luca
    Lavine, Joel E.
    Pajvani, Utpal B.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (468)
  • [47] PITAVASTATIN PREVENT FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS MODEL RAT
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Sugauchi, Fuminako
    Sakamoto, Tomoyuki
    Senda, Katsuhiro
    Joh, Takashi
    HEPATOLOGY, 2008, 48 (04) : 847A - 848A
  • [48] Pharmacological inhibition of RGD-binding integrins reverses liver fibrosis in a diet-based mouse model of nonalcoholic steatohepatitis
    Noritake, Hidenao
    Ulmasov, Barbara
    Carmichael, Peter
    Oshima, Kiyoko
    Griggs, David
    Kobayashi, Yoshimasa
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2017, 66 : 1048A - 1049A
  • [49] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    HEPATOLOGY, 1999, 30 (04) : 406A - 406A
  • [50] THE EFFECT OF A NOVEL MITOCHONDRIAL PYRUVATE CARRIER INHIBITOR ON MARKERS OF LIVER INFLAMMATION AND FIBROSIS IN A MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE
    Jarasvaraparn, Chaowapong
    Chan, Mandy
    Daemen, Sabine
    Schilling, Joel
    Chen, Yana
    Finck, Brian
    GASTROENTEROLOGY, 2020, 158 (06) : S1440 - S1441